http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1522359-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd569fbfa1953ca9b7b375510e4d2763 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-814 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-815 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6445 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate | 1975-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1978-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1522359-A |
| titleOfInvention | Purifying kallidinogenase |
| abstract | 1522359 Purifying Kallidinogenase (Kallikrein) SEIKAGAKU KOGYO CO Ltd 5 Dec 1975 3264/78 Divided out of 1522358 Heading C3H Kallidinogenase (Kallikrein) is purified by bringing an aqueous phase extract from the pancreas of a mammal into contact with a geltype weakly basic anion-exchange resin thereby causing the Kallidinogenase fraction to be adsorbed on the resin, and eluting the enzyme with an aqueous solution of an ammonium salt of a weak acid. Specified ammonium salts are the carbonate, bicarbonate, borate, mono- and di-hydrogen phosphate, phosphite, hypophosphite, formate, acetate, malate, citrate, lactate, oxalate, succinate, tartrate and valerate. Preferably adsorption on to the resin is effected between pH 4 and 8. The salt can be removed from the eluate by means of dialysis or ultrafiltration. |
| priorityDate | 1975-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.